Predictions
Valneva SE
Start price
Target price
Perf. (%)
€12.95
03.10.21
03.10.21
€20.00
03.10.22
03.10.22
15.83%
16.10.21
16.10.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Cellectis Nom.
Start price
Target price
Perf. (%)
€16.25
17.12.19
17.12.19
-
04.11.21
04.11.21
-43.42%
15.10.21
15.10.21
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€6.61
18.09.21
18.09.21
€3.00
18.09.22
18.09.22
-22.01%
02.10.21
02.10.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Nicox S.A.
Start price
Target price
Perf. (%)
€3.88
05.03.20
05.03.20
€6.00
04.11.21
04.11.21
-17.91%
29.09.21
29.09.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
04.09.21
04.09.21
€2.00
04.09.22
04.09.22
37.71%
18.09.21
18.09.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Valneva SE
Start price
Target price
Perf. (%)
€20.78
06.09.21
06.09.21
-
06.09.22
06.09.22
-39.56%
13.09.21
13.09.21
Risky Investment
Inventiva SA
Start price
Target price
Perf. (%)
€2.11
10.09.21
10.09.21
€12.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€2.11
10.09.21
10.09.21
€8.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€2.93
12.11.19
12.11.19
€8.40
04.11.21
04.11.21
293.86%
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€5.45
28.03.20
28.03.20
€7.00
04.11.21
04.11.21
18.44%
06.09.21
06.09.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment